Tactile Systems Technology Inc. (NASDAQ: TCMD) completed its IPO in July 2016. The Company is a market leading medical device company dedicated to advancing the standard of care for at–home treatment of lymphedema and chronic venous insufficiency. Tactile’s Flexitouch system is an innovative, patented medical device that simulates the gold-standard Manual Lymphatic Massage in cycle speed and pressure levels and effectively brings clinic-based treatment into the patient’s home.